HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.

AbstractBACKGROUND:
Recombinant hypoallergens that display reduced allergenicity but retain T-cell reactivity represent promising candidates to improve the safety and efficacy of allergen-specific vaccines or immunotherapy.
OBJECTIVE:
The current study reports the immunologic characterization of a hypoallergenic variant of the major mite allergen Der p 1.
METHODS:
The recombinant proform of Der p 1 (ProDer p 1) was expressed in Escherichia coli (ProDer p 1 coli), purified and characterized at the level of its secondary structure, and IgE and T-cell reactivities. Moreover, the prophylactic potential of ProDer p 1 coli vaccinations was evaluated in a murine Der p 1 sensitization model.
RESULTS:
After purification and refolding, ProDer p 1 coli remained aggregated with a higher beta-sheet content and altered Der p 1 conformational epitopes compared with the correctly folded monomeric ProDer p 1 produced in Chinese hamster ovary cells. Both ProDer p 1 forms were able to retain the Der p 1-specific T-cell reactivity but direct ELISA, competitive inhibition, and rat basophil leukemia assays clearly showed that ProDer p 1 coli displays a very weak IgE reactivity. Mice vaccinations with aggregated ProDer p 1 adjuvanted with alum induced a T(H)1-biased immune response that prevented the subsequent allergic response after Der p 1 sensitization and airway challenge with aerosolized mite extracts. Furthermore, ProDer p 1 coli treatment inhibited the development of airway eosinophilia and airway hyperresponsiveness to inhaled methacholine.
CONCLUSION:
Aggregated forms of Der p 1 could represent hypoallergens suitable for the prevention of mite allergy.
AuthorsDavid Walgraffe, Christel Mattéotti, Mohamed El Bakkoury, Lida Garcia, Céline Marchand, Dominique Bullens, Michel Vandenbranden, Alain Jacquet
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 123 Issue 5 Pg. 1150-6 (May 2009) ISSN: 1097-6825 [Electronic] United States
PMID19152967 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Antigens, Dermatophagoides
  • Arthropod Proteins
  • Bronchoconstrictor Agents
  • Interleukin-5
  • Recombinant Proteins
  • Vaccines
  • Methacholine Chloride
  • Immunoglobulin E
  • Interferon-gamma
  • Cysteine Endopeptidases
  • Dermatophagoides pteronyssinus antigen p 1
Topics
  • Allergens (immunology)
  • Animals
  • Antigens, Dermatophagoides (genetics, isolation & purification, pharmacology)
  • Arthropod Proteins
  • Basophils (drug effects, immunology, metabolism)
  • Bronchial Hyperreactivity (immunology, prevention & control)
  • Bronchoconstrictor Agents (pharmacology)
  • Cell Line, Tumor
  • Cloning, Molecular
  • Cysteine Endopeptidases
  • Disease Models, Animal
  • Eosinophilia (immunology, prevention & control)
  • Female
  • Humans
  • Hypersensitivity (immunology, prevention & control)
  • Immunoglobulin E (blood)
  • Interferon-gamma (biosynthesis, immunology)
  • Interleukin-5 (biosynthesis, immunology)
  • Methacholine Chloride (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Pyroglyphidae (immunology)
  • Rats
  • Recombinant Proteins (genetics, immunology)
  • T-Lymphocytes (drug effects, immunology, metabolism)
  • Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: